Jonathan C Goldsmith1. 1. Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA, Jonathan.goldsmith@fda.hhs.gov.
Authors: Erik H Hoyer; Dale M Needham; Levan Atanelov; Brenda Knox; Michael Friedman; Daniel J Brotman Journal: J Hosp Med Date: 2014-02-26 Impact factor: 2.960
Authors: James D Harrison; Andrew D Auerbach; Kathryn Quinn; Ellen Kynoch; Michelle Mourad Journal: J Gen Intern Med Date: 2014-11 Impact factor: 5.128